References
- Yin HS, Wolf MS, Dreyer BP, Sanders LM, Parker RM. Evaluation of consistency in dosing directions and measuring devices for pediatric nonprescription liquid medications. JAMA 2010; 304:2595–2602.
- Maignen F, Meglio S, Bidault I, Castot A. Acute toxicity of zidovudine. Analysis of the literature and number of cases at the Paris poison control center. Therapie 1993; 48:129–131.
- Falc V, Rodr guez D, Ribera E, . Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002; 34:838–846.
- Watts RG. Neutropenia. Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT. Wintrobe's Clinical Hematology. 12th. Philadelphia, PA: Lippincott Williams & Wilkins; 2009: 1527–1547.
- Kroon S, Worm AM. Zidovudine overdose. Int J STD AIDS 1991; 2:56–57.
- European Collaborative Study. Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1 infected mothers. AIDS 2004; 18:2009–2017.
- Sperling RS, Shapiro DE, McSherry GD, . Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS 1998; 12:1805–1813.
- Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic academia in human immunodeficiency virus-infected infants exposed to perinatal antiretroviral therapy. Pediatr Infect Dis 2003; 22: 782–788.
- Tourret J, Tostivint I, Tézenas DU, Montcel S, . Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis. Clin Infect Dis 2007; 45:779–782.
- Chiappini E, Galli L, Gabiano C, Gattinara GC, Martino A, Scolfaro C, de Martino M. Preventable zidovudine overdose during postnatal prophylaxis in healthy children born to HIV-1-positive mothers. AIDS 2008; 22:316–317.